Job Advert
NHS Scotland is committed to encouraging equality and diversity among our workforce and eliminating unlawful discrimination. The aim is for our workforce to be truly representative and for each employee to feel respected and able to give their best. To this end, NHS Scotland welcomes applications from all sections of society.
The Oncology Physics Department at Edinburgh Cancer Centre (ECC) is seeking a motivated and enthusiastic Band 8A Senior Clinical Scientist to join our team in this new post, to lead on the continued provision and development of Stereotactic Ablative Body Radiotherapy (SABR) for Oligometastic disease. This is an ideal opportunity to develop leadership skills and develop and embed this new post within ECC.
This will include complex treatment planning, patient specific QA, commissioning of new techniques, R&D and contribution to routine service and new technique development in the department. Previous experience with Varian hardware and software would be advantageous, but full training will be given.
ECC has an established intra-cranial Stereotactic service and is designated as the provider for the National Specialist Service for Benign Lesions for Scotland. Our SBRT service currently includes lung, bones, non-mobile lymph nodes and some spines and we intend to expand to adrenal, liver and mobile lymph nodes with this additional post. The postholder will contribute to the national Scottish SABR consortium along with other members of the multi-disciplinary team.
Applicants should have an honours degree in physics or other relevant subject, an accredited postgraduate degree and must be registered with the HCPC as a Clinical Scientist. If applicants do not already hold an RPA200 Certificate of Competence as a Medical Physics Expert, they will be supported and encouraged to submit their portfolio of evidence to attain this.
The department has 7 Varian linacs (including 1 Novalis TX & 1 TrueBeam STx) and 2 wide-bore Philips Brilliance CT’s with RPM. Eclipse and iPlan are used for external beam treatment planning with ARIA 13.6 as the Record and Verify system. We are currently upgrading to ARIA/ECLIPSE 16.6 and designing our paperlite workflow.
The department is an active participant in clinical trials, including SABR trials and has research links to the University of Edinburgh. It is expected interviews will take place on 22nd/23rd September 2022.
Informal enquiries are welcomed to Michael Trainer, Head of Treatment Planning (Michael.Trainer@nhslothian.scot.nhs.uk, 0131 537 2176).
This post requires the post holder to have a PVG Scheme membership/ record. If the post holder is not a current PVG member for the required regulatory group (i.e. child and/or adult) then an application will need to be made to Disclosure Scotland and deemed satisfactory before they can begin in post.